UWM Holdings Lands $1.65B from Oaktree and Ishbia, Rolls Out $400M Rights Offering

summarizeSummary

UWM Holdings Corp. raised $1.65 billion through a private placement of preferred stock and warrants with Oaktree Capital and insiders, and launched a $400 million backstopped rights offering—a lifeline that comes with heavy dilution and governance concessions.

check_boxKey Events · Financing and Capital Events · UWMC

• $1.65B Financing Closed

  For gross proceeds of $1.65 billion, UWM issued 1.5 million shares of Series A-1 Preferred Stock to Oaktree and 150,000 shares of Series A-2 Preferred Stock to the Ishbia Purchaser, along with 330 million warrants—165 million Class A at a $6.00 strike and 165 million Class B at a $2.00 strike.

• Preferred Stock Terms

  The preferred stock carries a 10% cash dividend rate, stepping up to 13% if not paid in cash, and compounds quarterly on a cumulative basis. Redemption premiums start at 10% and escalate to over 60% after year five. Oaktree's Series A-1 enjoys seniority and consent rights over major corporate actions.

• $400M Rights Offering Announced

  A rights offering for 200 million shares of Class A Common Stock is priced at the greater of $2.00 or 85% of the 10-day VWAP, fully backstopped by Ishbia and Oaktree. The record date is October 2, 2026, and the offering expires on November 12, 2026.

• Governance Changes

  Oaktree secures two board seats—with Nicholas Basso already appointed—a board observer, and consent rights over debt incurrence, affiliate transactions, and other key matters. The board expands from 10 to 12 directors.

auto_awesomeAnalysis · UWMC · Finance

In a move that reshapes its balance sheet, UWM Holdings Corp. closed a $1.65 billion financing with Oaktree Capital and entities tied to Mat Ishbia, issuing high-yield preferred stock and warrants for 330 million shares. The lifeline comes with steep terms: dividends of 10–13%, redemption premiums reaching 60%, and governance concessions that hand Oaktree two board seats and veto power over major corporate actions. At the same time, the company announced a $400 million rights offering backstopped by insiders, priced at the greater of $2.00 or 85% of market—a deeply dilutive structure that, together with the warrants, could nearly double the share count if fully exercised. While the financing addresses near-term liquidity needs, including redeeming 2027 notes and repaying MSR facilities, it embeds significant future dilution and creditor-friendly controls. The stock trades near its 52-week low, underscoring the distressed nature of the raise.